Clinical Trial Update: A Study to Assess the Effect of RO4607381 in Patients With Relatively Low Levels of High Density Lipoprotein-Cholesterol (HDL-C) [Phase 2]

View source ↗

Summary

Phase 2 trial assessing RO4607381 in patients with relatively low HDL-cholesterol completed with posted results.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Dyslipidemia

Drugs mentioned

• RO4607381

Snippet

Sponsor: Hoffmann-La Roche | Conditions: Dyslipidemia | Phase 2 | Status: COMPLETED | Results posted: 2020-01-02